openPR Logo
Press release

Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025

02-11-2019 04:17 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Rise in Prevalence of Migraine Drives the Migraine Drugs Market |

Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.

The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr_ss

However, the side effects of migraine medications are expected to limit market growth. On the contrary, it is expected that new emerging therapies / medications for the treatment of migraine and growth opportunities in emerging countries present opportunities for market growth during the forecast period.

By type, abortifacient drugs accounted for more than three quarters of the global market for migraine drugs in 2017. In addition, by administration, the oral segment is expected to grow at the highest rate of 3.4% during the forecast period.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr_ss

Key Market Players:

• Abbott Laboratories
• Allergan Plc.
• AstraZeneca
• Eisai Co. Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories

Key Findings of Migraine Drugs Market:

•North America occupied the two-fifths of the world market for migraine medicines.

•It is anticipated that Oral will grow with the highest CAGR throughout the forecast period.

•It is expected that Europe will occupy more than a quarter of the market share of the global market for migraine drugs by 2025.

•It is anticipated that Asia-Pacific will grow at the highest rate during the analysis period, followed by LAMEA.

Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/migraine-drugs-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025 here

News-ID: 1577855 • Views:

More Releases from Allied Market Research

3D Rendering Services Market is Forecasted to Attain US$ 61.65 Billion by 2026, At a Booming 28.10% Growth Rate
3D Rendering Services Market is Forecasted to Attain US$ 61.65 Billion by 2026, …
The global 3D Rendering Services industry was valued at $8.56 billion in 2018, and is projected to reach $61.65 billion by 2026, growing at a CAGR of 28.10% from 2019 to 2026. Modelling service is expected to experience significant growth in the upcoming years, as these services are becoming extremely popular marketing services that are used for design, presentation, and sales of any residential or commercial buildings. Request Sample Report: https://www.alliedmarketresearch.com/request-sample/6174 3D rendering
Fuel Cell UAV Market to Grow at a CAGR of 13.4% and will Reach USD 5.4 billion by 2032
Fuel Cell UAV Market to Grow at a CAGR of 13.4% and will Reach USD 5.4 billion b …
The growth of the global 𝐅𝐮𝐞𝐥 𝐂𝐞𝐥𝐥 𝐔𝐀𝐕 𝐌𝐚𝐫𝐤𝐞𝐭 is driven by factors such as rise in demand for improved surveillance, increase in need for higher payload capacity UAVs, and supportive growth through regulatory compliance. The global fuel cell UAV market size was valued at $1.6 billion in 2022, and is projected to reach $5.4 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬
Navigating Growth Trajectories in the Global Bio-based PET Market: Trends, Drivers, and Forecasts
Navigating Growth Trajectories in the Global Bio-based PET Market: Trends, Drive …
Allied Market Research recently released a comprehensive report titled "Global Bio-based PET Market," which highlights that the market reached an estimated value of $441.3 million in 2021 and is projected to reach $941.4 million by 2031, exhibiting a robust compound annual growth rate (CAGR) of 7.9% from 2022 to 2031. The report offers detailed insights into key investment areas, winning strategies, drivers, opportunities, market size estimations, competitive landscape, and evolving
Fraud Detection and Prevention Market was valued at $29.5 billion in 2022 and to generate $252.7 billion by 2032
Fraud Detection and Prevention Market was valued at $29.5 billion in 2022 and to …
The fraud detection and prevention industry was valued at $29.46 billion in 2022, and is estimated to reach $252.7 billion by 2032, growing at a CAGR of 24.3% from 2023 to 2032. The retail sector registered highest market growth rate during the forecast period. Rise in penetration of mobiles and internet across retail sector propels adoption of fraud detection and prevention solutions in the Retail sector. In addition, data from the

All 5 Releases


More Releases for Migraine

Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help
Increasing incidences of migraine sufferers driving the Anti-Migraine Drugs Mark …
Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and